HLMVX
Price
$37.33
Change
-$0.02 (-0.05%)
Updated
Sep 17 closing price
Net Assets
580.22M
RNPFX
Price
$73.44
Change
-$0.20 (-0.27%)
Updated
Sep 17 closing price
Net Assets
162.63B
Interact to see
Advertisement

HLMVX vs RNPFX

Header iconHLMVX vs RNPFX Comparison
Open Charts HLMVX vs RNPFXBanner chart's image
Harding Loevner Global Equity Inst
Price$37.33
Change-$0.02 (-0.05%)
VolumeN/A
Net Assets580.22M
American Funds New Perspective R5
Price$73.44
Change-$0.20 (-0.27%)
VolumeN/A
Net Assets162.63B
HLMVX vs RNPFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
HLMVX vs. RNPFX commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLMVX is a Buy and RNPFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPFX has more cash in the bank: 163B vs. HLMVX (580M). RNPFX pays higher dividends than HLMVX: RNPFX (0.72) vs HLMVX (0.31). HLMVX was incepted earlier than RNPFX: HLMVX (16 years) vs RNPFX (23 years). HLMVX (0.87) is less costly to investors than RNPFX (0.46). HLMVX is a more actively managed with annual turnover of: 27.00 vs. RNPFX (24.00). RNPFX has a lower initial minimum investment than HLMVX: RNPFX (250) vs HLMVX (100000). RNPFX annual gain was more profitable for investors over the last year : 15.12 vs. HLMVX (-14.15). RNPFX return over 5 years is better than : 40.56 vs. HLMVX (-11.71).
HLMVXRNPFXHLMVX / RNPFX
Total Expense Ratio0.860.46187%
Annual Report Gross Expense Ratio0.870.46189%
Fund Existence16 years23 years-
Gain YTD10.20918.37556%
Front LoadN/AN/A-
Min. Initial Investment10000025040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets580M163B0%
Annual Yield % from dividends0.310.7243%
Returns for 1 year-14.1515.12-94%
Returns for 3 years17.7352.5534%
Returns for 5 years-11.7140.56-29%
Returns for 10 years25.71104.4525%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PCOR72.560.84
+1.17%
Procore Technologies
MTX63.510.30
+0.47%
Minerals Technologies
GLUE6.36-0.12
-1.78%
Monte Rosa Therapeutics
VRAX0.61-0.02
-3.19%
Virax Biolabs Group Limited
TDTH0.89-0.03
-3.64%
Trident Digital Tech Holdings Ltd